You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: thrombolytic treatment does not reduce the risk of recurrent pulmonary embolism and death more than heparin

https://doi.org/10.1136/ebm.10.2.41

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • For correspondence: Dr J W Eikelboom, Depatment of Haematology, Royal Perth Hospital, Perth, West Australia, Australia. John.eikelboomhealth.wa.gov.au

    • Source of funding: no external funding.

    Linked Articles

    • Glossary
      Glossary
      BMJ Publishing Group Ltd
      BMJ Evidence-Based Medicine 2005; 10 64-64 Published Online First: 30 Mar 2005. doi: 10.1136/ebm.10.2.64